Pharma major AstraZeneca, headquartered in Cambridge, UK, has amended its collaboration agreement with US pharmaceutical company Ironwood Pharmaceuticals. AstraZeneca now has sole responsibility for the R&D, manufacture and commercialisation of the irritable bowel syndrome (IBS) treatment Linzess in mainland China, Hong Kong and Macau.
US biotechnology company, Aldevron which produces plasmid DNA, proteins, mRNA and antibodies, is building a gene therapy manufacturing campus at its headquarters in Fargo, ND. Three buildings will be built over the next three to five years to support genetic medicine.
UK-based global petrochemicals giant Ineos is investing $2bn in building its first ever manufacturing plants in Saudi Arabia.
Chemicals major BASF has opened a research centre for catalyst and process development at its Verbund site
UK headquartered Abcam, a global life sciences company, has acquired US-based Calico Biolabs
Biomunex Pharmaceuticals, headquartered in Paris, France, has signed a licensing agreement with French pharma major Sanofi
International life sciences measurement and testing company LGC, headquartered in London, UK, has acquired US-based SeraCare Life Sciences.
Bayer is to divest its animal health business as a part of a major restructuring programme designed to strengthen its life science businesses.
US healthcare company Alliqua BioMedical is merging with San Fransciso-based biopharmaceutical company Adynxx.
Alcon, the eye care unit of Swiss drug major Novartis, will locate its future global headquarters in the Canton of Geneva.